Trials / Unknown
UnknownNCT00576082
Borrelia Species in Cutaneous Lyme Borreliosis
DIVERSITY OF BORRELIA SPECIES INVOLVED IN CUTANEOUS MANIFESTATIONS OF LYME BORRELIOSIS IN FRANCE
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 900 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to identify the species of Borrelia involved in the dermatologic manifestations of Lyme borreliosis in France. Indeed, in Europe, as opposed to North America, many bacterial species are involved in Lyme borreliosis. Yet, very few is known about the prevalence and distribution of different bacteriological species that account for the disease in France. Thus, this a nation-wide study in which all French dermatologists are invited to participate. Every adult patient presenting with one of the cutaneous manifestation of Lyme borreliosis: erythema migrans, lymphocytoma or acrodermatitis chronica atrophicans can be included in the study. If the patient agrees participating, after information and written consent, a cutaneous biopsy will be performed in order to isolate Borrelia by means of culture and PCR. An estimated 400 biopsies should be performed within 2 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cutaneous biopsy | Cutaneous biopsy in order to search Borrelia by means of culture and PCR in this tissue sample |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
- First posted
- 2007-12-18
- Last updated
- 2022-06-30
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00576082. Inclusion in this directory is not an endorsement.